The Valley Desk

NCT03941093 · Interventional trial

Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer

Overall registry status Completed

Phase 3

Conditions Pancreatic Cancer Non-resectable

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov